Latest Earnings Results: Q2 '26
Estimated EPS
-$0.23
Reported EPS
-$0.34
Surprise
-44.68%
Estimated Rev
$17.82M
Reported Rev
$17.78M
Surprise
-0.22%
• Reported GAAP EPS of -$0.34 up 32.00% YoY • Reported revenue of $17.78M up 10.63% YoY • Rockwell Medical reiterates its 2026 annual guidance of $70.0M to $75.0M in net sales, 18% to 22% gross margin, $1.0M to $2.0M in Adjusted EBITDA, and positive operating cash flow.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.18 | -- | -- | N/A |
Q2 '26 | -$0.23 | -$0.34 | -44.68% | MISSED |
Q1 '26 | -$0.03 | -$0.40 | -1500.00% | MISSED |
Q4 '25 | $0.02 | -$0.01 | -150.00% | MISSED |
Q3 '25 | -$0.05 | -$0.05 | -11.11% | MISSED |